Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease

Association of African Ancestry–Specific APOE Missense Variant R145C With Risk of Alzheimer Disease

(2023) Yann Le Guen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Why Diverse Clinical Trial Participation Matters

(2023) Aaron L. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Step Forward in the Fight Against Dementia—Are We There Yet?

(2023) David A. Wolk et al.   JAMA Neurology

What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?

(2022) Joshua D. Grill et al.   JAMA Neurology

Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia

(2022) Consuelo H. Wilkins et al.   JAMA Neurology

Lecanemab in Early Alzheimer’s Disease

(2022) Christopher H. van Dyck et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Reporting of Race and Ethnicity in Medical and Science Journals

(2021) Annette Flanagin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

(2021) Chad J. Swanson et al.   Alzheimers Research & Therapy

Assessment of Racial/Ethnic Disparities in Timeliness and Comprehensiveness of Dementia Diagnosis in California

(2021) Elena Tsoy et al.   JAMA Neurology

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

(2021) Rema Raman et al.   JAMA Network Open

Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria

(2021) Sanne Franzen et al.   Alzheimers & Dementia

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel

(2020) Brian W. Kunkle et al.   JAMA Neurology

Together We Make the Difference: National Strategy for Recruitment and Participation in Alzheimer’s and Related Dementias Clinical Research

(2020) Cerise L Elliott   ETHNICITY & DISEASE

Assessment of Racial Disparities in Biomarkers for Alzheimer Disease

(2019) John C. Morris et al.   JAMA Neurology

Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer’s Disease Center

(2019) Teresa Jenica Filshtein et al.   JOURNAL OF ALZHEIMERS DISEASE

Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals

(2018) Jennifer S. Rabin et al.   JAMA Neurology

Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years

(2018) Kevin A. Matthews et al.   Alzheimers & Dementia

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

(2018) Ganesh M. Babulal et al.   Alzheimers & Dementia

Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers

(2017) Jennifer C. Howell et al.   Alzheimers Research & Therapy

The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts

(2017) Julie A. Schneider et al.   JOURNAL OF ALZHEIMERS DISEASE

Neuropathologic differences by race from the National Alzheimer's Coordinating Center

(2016) Neill R. Graff-Radford et al.   Alzheimers & Dementia

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

(2016) Eric R. Siemers et al.   Alzheimers & Dementia

The ARIC-PET amyloid imaging study

(2016) Rebecca F. Gottesman et al.   NEUROLOGY

Mixed pathology is more likely in black than white decedents with Alzheimer dementia

(2015) Lisa L. Barnes et al.   NEUROLOGY

Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

(2015) Enchi Liu et al.   NEUROLOGY

Multiple pathologies are common and related to dementia in the oldest-old

(2015) Claudia H. Kawas et al.   NEUROLOGY

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

(2012) Christopher M Clark et al.   LANCET NEUROLOGY